For the year ending 2025-12-31, ZBIO has $383,640K in assets. $141,496K in debts. $110,641K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 110,641 | |||
| Short-term investments | 232,551 | |||
| Prepaid expenses and other current assets | 7,979 | |||
| Total current assets | 351,171 | |||
| Property and equipment, net | 34 | |||
| Operating lease right-of-use assets, net | 1,354 | |||
| Long-term investments | 17,272 | |||
| Other non-current assets | 13,809 | |||
| Total assets | 383,640 | |||
| Accounts payable | 7,111 | |||
| Accrued expenses | 54,423 | |||
| Operating lease liabilities, current | 1,115 | |||
| Total current liabilities | 62,649 | |||
| Royalty obligation | 78,636 | |||
| Operating lease liabilities, less current portion | 211 | |||
| Total long-term liabilities | 78,847 | |||
| Total liabilities | 141,496 | |||
| Common stock, par value 0.0001 per share 175,000,000 shares authorized at december 31, 2025 and december 31, 2024, respectively 54,485,518 and 41,793,412 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 5 | |||
| Additional paid-in capital | 1,007,331 | |||
| Accumulated other comprehensive (loss) income | -64 | |||
| Accumulated deficit | -765,128 | |||
| Total stockholders' equity | 242,144 | |||
| Total liabilities and stockholders' equity | 383,640 | |||
Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO)